SiBionics wins CE mark for 14-day CGM - Drug Delivery Business
WEBOct 31, 2023 · SiBionics announced today that it received CE mark approval in Europe for its GS1 continuous glucose monitoring (CGM) system. The company designed its CGM system to provide healthcare providers and patients with data necessary for maintaining glucose control. It offers 14 days of calibration-free …
Stevanato Group is constructing a new facility in Indiana
WEBOct 4, 2021 · Stevanato Group (NYSE:STVN) announced today that it will begin construction on a new U.S. facility in Fishers, Indiana. Piombino Dese, Italy-based Stevanato Group will begin construction on the new facility this month with expectations for the site to be operational in 2023. According to a …
The company behind Narcan looks toward a treatment for fentanyl ...
WEBMar 13, 2018 · A nasal spray designed to reverse opioid overdoses called Narcan has become a life-saving tool used by police departments and communities around the country. Now, the company that created Narcan – Opiant Pharmaceuticals (NSDQ: OPNT) – is hoping that its latest drug-device combination can …
Drug Delivery Business
WEBSep 6, 2023 · CorFlow Therapeutics announced today that it raised €44 million ($48.5 million) to support its novel diagnostic and drug delivery platform. Broadview Ventures and Panakes Partners led the financing round. 415 Capital, Merieux Equity Partners, Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners, M&L Investments, Unorthodox Ventures, KOFA Healthcare and Monte Carlo Capital ...
Kindeva wins £33M grant to enhance drug-delivering inhalers
WEBAugust 4, 2023 By Sean Whooley. Kindeva Drug Delivery announced that it received a grant from a UK fund worth a $42.2 million (£33 million) investment. The grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSIMF) aims to help Kindeva enhance inhaler manufacturing and sustainability. Funds improve Kindeva’s ...
Lilly partners with four companies on insulin pen tech
WEBMay 6, 2021 By Nancy Crotti. Eli Lilly (NYSE:LLY) today announced deals with four companies whose diabetes management tech will work with Lilly’s latest insulin pen. The Tempo Pen is a modified version of Lilly’s existing prefilled, disposable insulin pen to which the Tempo Smart Button — in late-stage development – attaches. Through ...
Abbott breaks ground on FreeStyle Libre plant in Ireland
WEBApr 14, 2023 · Abbott (NYSE:ABT) today broke ground on a new FreeStyle Libre manufacturing facility in Kilkenny, Ireland. Jared Watkin, SVP for Abbott’s diabetes care business, shared the news of the groundbreaking in a LinkedIn post. In August 2022, Ireland announced Abbott’s plans to spend €440 million ($450 million) to expand its operations in Ireland.
Beta Bionics integrates iLet bionic pancreas with Dexcom G7
WEBDec 7, 2023 · The iLet bionic pancreas and the Dexcom G7 CGM. [Image courtesy of Beta Bionics] Beta Bionics announced today that it began the U.S. launch of its iLet bionic pancreas with the Dexcom G7 continuous glucose monitor (CGM). The launch marks the second G7-compatible automated insulin delivery system to hit the market in as many days.
Update: Insulet opens manufacturing facility in Acton, Mass.
WEBFebruary 16, 2017 By Sarah Faulkner. Insulet (NSDQ: PODD) said yesterday that it acquired a manufacturing facility in Acton, Mass. The Billerica, Mass.-based company said that its new facility will allow Insulet to more efficiently manufacture its OmniPod system compared to 4 of the company’s manufacturing lines at its contract manufacturer ...
Phillips-Medisize, Subcuject team on wearable osmotic bolus injector
WEBFeb 4, 2021 · Phillips-Medisize announced today that it is collaborating with Subcuject to bring a wearable bolus injector to market.. Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the on-body delivery system technology that is based on osmosis is now available for the next stage of drug-specific wearable injector solution after Subcuject filed for intellectual property ...